Both in Medical Labs
BioNexus Gene Lab vs Aclarion
Over the past year BGLC returned −76.8% and ACON returned −68.8%; their daily moves had a correlation of 0.14.
BGLC −76.8% ACON −68.8%Growth of $1, one year, split-adjusted
| Metric | BGLC | ACON |
|---|---|---|
| Price | $1.27 | $2.38 |
| Market cap | $3.7M | $6.9M |
| Today | −2.31% | −2.46% |
| 1 month | −18.1% | −0.8% |
| 6 months | −45.3% | −22.7% |
| Year to date | −67.8% | −48.3% |
| 1 year | — | −68.8% |
| Revenue growth (YoY) | −96.6% | +30.5% |
| Gross margin | 17.0% | 32.9% |
| Net margin | −376.1% | −10899.5% |
| P/E (TTM) | — | — |
| Price / sales | 1.2× | 81.9× |
| Net cash | $1.2M | $16.3M |
| Dividend yield | — | — |
| Volatility (60d) | 68.5% | 70.3% |
| Short % of float | 0.7% | 3.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).